Close
Blog & Resources Camargo Blog August 1st, 2010

Still Submitting Paper ANDA Applications?

Experience that shows electronic filing of NDA’s, IND’s and ANDA’s helps speed up the review and approval of these applications. Perhaps because of the software cost and extensive training needed some companies still submit paper applications. Effective today, August 1, 2010, the address to submit the paper ANDA is:

Office of Generic Drugs (HFD—600)
Center for Drug Evaluation and Research, Food and Drug Administration
Metro Park North VII, 7620 Standish Pl.
Rockville, MD 20855.

This address is also used when mailing IND’s that are used to support ANDA’s.

At Camargo, we advise clients to submit electronic applications whenever possible. We have the software and training needed to accomplish this task. We have set up an document management system that allows each client to securely view all of their documents and to view the eCTD submission at any time.



Get Our Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our solutions or contact us.


Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.


Contact
Headquarters
9825 Kenwood Road,
Suite 203
Cincinnati, OH 45242
Durham Office
2505 Meridian Parkway,
Suite 150
Durham, NC 27713
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights